| 21.13 Data as of 1:44pm ET | +0.465 / +2.25%Today’s Change | 9.95 Today|||52-Week Range 26.50 | +87.28% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $414.1M |
Hyperion Therapeutics, Inc. 601 Gateway Boulevard South San Francisco California 94080 |

| Donald J. Santel | President, Chief Executive Officer & Director |
| Jeffrey S. Farrow | Chief Financial Officer & Secretary |
| Dion F. Coakley, PhD | Global Vice President-Clinical Operations |
| Bruce F. Scharschmidt, MD | Chief Medical Officer & Senior Vice President |
| Christine A. Nash, MBA | Chief Commercial Officer & Senior Vice President |